<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for na_neg 1647608233332 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_HYPOXIA'>HALLMARK_HYPOXIA</a></td><td><a href='HALLMARK_HYPOXIA.html'>Details ...</a></td><td>101</td><td>-0.43</td><td>-2.12</td><td>0.000</td><td>0.004</td><td>0.004</td><td>1864</td><td>tags=50%, list=22%, signal=63%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_GLYCOLYSIS'>HALLMARK_GLYCOLYSIS</a></td><td><a href='HALLMARK_GLYCOLYSIS.html'>Details ...</a></td><td>102</td><td>-0.41</td><td>-1.98</td><td>0.000</td><td>0.013</td><td>0.027</td><td>1334</td><td>tags=34%, list=16%, signal=40%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_INTERFERON_GAMMA_RESPONSE'>HALLMARK_INTERFERON_GAMMA_RESPONSE</a></td><td><a href='HALLMARK_INTERFERON_GAMMA_RESPONSE.html'>Details ...</a></td><td>98</td><td>-0.41</td><td>-1.96</td><td>0.000</td><td>0.011</td><td>0.036</td><td>1095</td><td>tags=31%, list=13%, signal=35%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_CHOLESTEROL_HOMEOSTASIS'>HALLMARK_CHOLESTEROL_HOMEOSTASIS</a></td><td><a href='HALLMARK_CHOLESTEROL_HOMEOSTASIS.html'>Details ...</a></td><td>35</td><td>-0.45</td><td>-1.75</td><td>0.013</td><td>0.037</td><td>0.144</td><td>2025</td><td>tags=51%, list=24%, signal=67%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_APICAL_JUNCTION'>HALLMARK_APICAL_JUNCTION</a></td><td><a href='HALLMARK_APICAL_JUNCTION.html'>Details ...</a></td><td>93</td><td>-0.36</td><td>-1.71</td><td>0.005</td><td>0.036</td><td>0.174</td><td>1697</td><td>tags=40%, list=20%, signal=49%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_UV_RESPONSE_DN'>HALLMARK_UV_RESPONSE_DN</a></td><td><a href='HALLMARK_UV_RESPONSE_DN.html'>Details ...</a></td><td>70</td><td>-0.35</td><td>-1.54</td><td>0.029</td><td>0.106</td><td>0.490</td><td>1350</td><td>tags=33%, list=16%, signal=39%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_ALLOGRAFT_REJECTION'>HALLMARK_ALLOGRAFT_REJECTION</a></td><td><a href='HALLMARK_ALLOGRAFT_REJECTION.html'>Details ...</a></td><td>61</td><td>-0.35</td><td>-1.51</td><td>0.032</td><td>0.111</td><td>0.571</td><td>1662</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_TGF_BETA_SIGNALING'>HALLMARK_TGF_BETA_SIGNALING</a></td><td><a href='HALLMARK_TGF_BETA_SIGNALING.html'>Details ...</a></td><td>32</td><td>-0.40</td><td>-1.51</td><td>0.041</td><td>0.099</td><td>0.577</td><td>3001</td><td>tags=66%, list=35%, signal=101%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_ESTROGEN_RESPONSE_EARLY'>HALLMARK_ESTROGEN_RESPONSE_EARLY</a></td><td><a href='HALLMARK_ESTROGEN_RESPONSE_EARLY.html'>Details ...</a></td><td>101</td><td>-0.31</td><td>-1.49</td><td>0.022</td><td>0.098</td><td>0.615</td><td>1616</td><td>tags=33%, list=19%, signal=40%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_MYOGENESIS'>HALLMARK_MYOGENESIS</a></td><td><a href='HALLMARK_MYOGENESIS.html'>Details ...</a></td><td>82</td><td>-0.31</td><td>-1.45</td><td>0.054</td><td>0.116</td><td>0.706</td><td>2338</td><td>tags=49%, list=27%, signal=67%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION'>HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION</a></td><td><a href='HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION.html'>Details ...</a></td><td>85</td><td>-0.31</td><td>-1.45</td><td>0.037</td><td>0.107</td><td>0.709</td><td>805</td><td>tags=22%, list=9%, signal=24%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_APOPTOSIS'>HALLMARK_APOPTOSIS</a></td><td><a href='HALLMARK_APOPTOSIS.html'>Details ...</a></td><td>85</td><td>-0.29</td><td>-1.40</td><td>0.068</td><td>0.130</td><td>0.816</td><td>823</td><td>tags=20%, list=10%, signal=22%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_KRAS_SIGNALING_DN'>HALLMARK_KRAS_SIGNALING_DN</a></td><td><a href='HALLMARK_KRAS_SIGNALING_DN.html'>Details ...</a></td><td>68</td><td>-0.31</td><td>-1.38</td><td>0.071</td><td>0.129</td><td>0.836</td><td>855</td><td>tags=24%, list=10%, signal=26%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_HEDGEHOG_SIGNALING'>HALLMARK_HEDGEHOG_SIGNALING</a></td><td><a href='HALLMARK_HEDGEHOG_SIGNALING.html'>Details ...</a></td><td>18</td><td>-0.43</td><td>-1.37</td><td>0.118</td><td>0.133</td><td>0.866</td><td>1394</td><td>tags=39%, list=16%, signal=46%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_INTERFERON_ALPHA_RESPONSE'>HALLMARK_INTERFERON_ALPHA_RESPONSE</a></td><td><a href='HALLMARK_INTERFERON_ALPHA_RESPONSE.html'>Details ...</a></td><td>57</td><td>-0.32</td><td>-1.37</td><td>0.095</td><td>0.125</td><td>0.868</td><td>1866</td><td>tags=35%, list=22%, signal=45%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_COAGULATION'>HALLMARK_COAGULATION</a></td><td><a href='HALLMARK_COAGULATION.html'>Details ...</a></td><td>65</td><td>-0.30</td><td>-1.31</td><td>0.115</td><td>0.163</td><td>0.953</td><td>2127</td><td>tags=43%, list=25%, signal=57%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_P53_PATHWAY'>HALLMARK_P53_PATHWAY</a></td><td><a href='HALLMARK_P53_PATHWAY.html'>Details ...</a></td><td>103</td><td>-0.26</td><td>-1.28</td><td>0.107</td><td>0.182</td><td>0.973</td><td>836</td><td>tags=16%, list=10%, signal=17%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_PEROXISOME'>HALLMARK_PEROXISOME</a></td><td><a href='HALLMARK_PEROXISOME.html'>Details ...</a></td><td>56</td><td>-0.30</td><td>-1.28</td><td>0.150</td><td>0.173</td><td>0.973</td><td>1016</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_IL2_STAT5_SIGNALING'>HALLMARK_IL2_STAT5_SIGNALING</a></td><td><a href='HALLMARK_IL2_STAT5_SIGNALING.html'>Details ...</a></td><td>85</td><td>-0.26</td><td>-1.22</td><td>0.155</td><td>0.227</td><td>0.994</td><td>2483</td><td>tags=47%, list=29%, signal=66%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HALLMARK_INFLAMMATORY_RESPONSE'>HALLMARK_INFLAMMATORY_RESPONSE</a></td><td><a href='HALLMARK_INFLAMMATORY_RESPONSE.html'>Details ...</a></td><td>74</td><td>-0.26</td><td>-1.18</td><td>0.192</td><td>0.250</td><td>0.998</td><td>2319</td><td>tags=43%, list=27%, signal=59%</td></tr><tr><td class='lessen'>21</td><td>HALLMARK_IL6_JAK_STAT3_SIGNALING</td><td></td><td>39</td><td>-0.29</td><td>-1.17</td><td>0.235</td><td>0.255</td><td>0.998</td><td>2157</td><td>tags=44%, list=25%, signal=58%</td></tr><tr><td class='lessen'>22</td><td>HALLMARK_COMPLEMENT</td><td></td><td>94</td><td>-0.24</td><td>-1.16</td><td>0.212</td><td>0.260</td><td>0.999</td><td>1514</td><td>tags=29%, list=18%, signal=35%</td></tr><tr><td class='lessen'>23</td><td>HALLMARK_HEME_METABOLISM</td><td></td><td>98</td><td>-0.24</td><td>-1.15</td><td>0.235</td><td>0.256</td><td>1.000</td><td>1616</td><td>tags=26%, list=19%, signal=31%</td></tr><tr><td class='lessen'>24</td><td>HALLMARK_APICAL_SURFACE</td><td></td><td>18</td><td>-0.30</td><td>-0.98</td><td>0.499</td><td>0.481</td><td>1.000</td><td>1131</td><td>tags=28%, list=13%, signal=32%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>na<b>&nbsp<a href='gsea_report_for_na_neg_1647608233332.tsv'>[plain text format]</a></caption></table></div><br></body></html>